Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

China flag China · Delayed Price · Currency is CNY
17.45
+0.25 (1.45%)
Jul 15, 2026, 3:00 PM CST
Market Cap2.88B -37.3%
Revenue (ttm)1.30B +3.8%
Net Income11.06M -92.4%
EPS0.07 -92.3%
Shares Out 167.44M
PE Ratio257.36
Forward PE11.24
Dividend0.25 (1.45%)
Ex-Dividend DateJun 3, 2026
Volume6,639,264
Open17.03
Previous Close17.20
Day's Range17.00 - 17.85
52-Week Range14.61 - 40.19
Beta0.48
Analystsn/a
Price Targetn/a
Earnings DateAug 22, 2026

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manuf... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 617
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688687
Full Company Profile

Financial Performance

In 2025, SHA:688687's revenue was 1.32 billion, an increase of 7.35% compared to the previous year's 1.23 billion. Earnings were 30.60 million, a decrease of -78.51%.

Financial Statements